Professor Mark R. Miller is a Personal Chair of the Environment and Health (Senior Research Scientist) working in the Centre for Cardiovascular Science at the University of Edinburgh, United Kingdom. Mark’s research addresses the health effects of air pollution. A notable focus has been the biological pathways by which the particles in vehicle exhaust cause adverse effects in the cardiovascular system. His work encompasses a broad range of approaches including in vivo models of disease and controlled exposure to air pollutants in human subjects. Mark is an Editor of the journal Particle & Fibre Toxicology. He is the Outgoing Chair of the World Heart Federation Air Pollution and Climate Change Expert Group, and a member of the European Society of Cardiology Taskforce on the Environment and Sustainability. He is a member of the Scottish Government Air Quality Advisory Group and an Expert Member of the Committee on the Medical Effects of Air Pollution (COMEAP), which advises the UK governmental Department of Health on this subject. Mark’s research findings have received extensive coverage in the national and international media, and featured in documentaries on UK television. His work was highlighted as a case study in the DEFRA (UK Government) Clean Air Strategy 2019, contributed to the 2021 World Health Organization Global Air Quality Guidelines, and the Chief Medical Officer for England’s Annual Report: Air Pollution (2022).

Dr Cheng Hwee Soh is a postdoctoral research officer who is driven by a desire to expand human healthspan as lifespans have increased over the past decades. With a background in geriatric rehabilitation, Dr Soh works to predict and improve clinical outcomes for patients at risk, leading to significant advancements that are translated into clinical practice. Currently working in the Baker Institute's Imaging Research lab, Dr Soh's research focus is centered around predicting Stage B Heart Failure and coronary artery disease among vulnerable cohorts, particularly cancer survivors. The ultimately goal is to identify an effective strategy to screen for these subclinical diseases and increase the prescription rate of preventive interventions.

Zhaleh Ataei is a medical doctor currently working as an honorary researcher at Baker Heart and Diabetes Institute in Melbourne. Zhaleh has been doing her research project under the supervision of Professor Erin Howden and has a major interest in preventive Cardiology.

Anand is a 1st-year Cardiology Advanced Trainee at Barwon Health. His research interests lie in preventative cardiology, with a focus on risk factor modification, lifestyle interventions, and early detection strategies to reduce the burden of cardiovascular disease. He is passionate about integrating evidence-based prevention strategies into clinical practice and improving patient outcomes through multidisciplinary collaboration. Anand is also involved in medical education and enjoys mentoring junior doctors and medical students.

Quan Li is an epidemiologist and a first-year PhD candidate at The Prince Charles Hospital and the University of Queensland. With a background in Preventive Medicine (Bachelor’s) and a Master of Public Health, his research focuses on the burden and outcomes of diabetes on the healthcare system, particularly diabetes-related complications such as cardiovascular and cerebrovascular diseases. Quan is especially interested in health data analytics, policy implications, and improving healthcare outcomes.

Georgia is a thermal and cardiovascular physiologist, recently funded by a NHMRC Emerging Leader Investigator grant. She is the Aging and Chronic disease theme lead within the Heat and Health Research Centre, a core researcher within SOLVE-CHD at the University of Sydney and forms part of the World Heart Federation Expert Group on Air Pollution and Climate Change. Her research focuses on implementing sustainable, accessible adaptation strategies to reduce heat-related health risks in vulnerable populations, particularly older adults, and those with cardiovascular disease.